BioPharma Credit
data as at: 28/05/2020| Company website | |
| Objective | To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. |
| Management group | Pharmakon Advisors |
| AIC sector | Debt - Direct Lending |
| Launch date | 27/03/2017 |
| Financial year end | December |
| Domicile | United Kingdom |
Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.
| Total assets (m) | Price (last close) | Price (bid) | Price (offer) | NAV | Dividend dates | Discount/ premium (%) | Gearing (%) | 5yr dividend growth (%) p.a. | Dividend yield (%) |
|---|---|---|---|---|---|---|---|---|---|
| 1,363.6 | 0.96 | 0.96 | 0.96 | 0.99 | Mar, Jun, Sep, Dec | -3.3 | 0 | N/A | 7.3 |
Dividends
Dividends displayed in traded currency.
| Ex-Dividend Date | Dividend amount | Dividend type | Special dividend | Financial year |
|---|---|---|---|---|
| 21/05/2020 | 0.018 | Income | No | 2020 |
| 27/02/2020 | 0.018 | Income | No | 2019 |
| 27/02/2020 | 0.013 | Capital | Yes | 2019 |
| 14/11/2019 | 0.018 | Income | No | 2019 |
| 15/08/2019 | 0.018 | Income | No | 2019 |
| Dividend cover (years) | Revenue reserves (m) |
|---|---|
| 0.43 | 41.69 |
Trading information
| ISIN | TIDM | Traded currency |
|---|---|---|
| GB00BDGKMY29 | BPCR | USD |
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 2,772,654 | 12,933,745 | 265,245,596 | 0 |
| Average | N/A | 714,480 | 1,052,170 | 0 |
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 2.66 | 12.38 | 263.94 | 0.00 |
| Average | N/A | 0.68 | 1.05 | 0.00 |
Data provided by Morningstar. Company documents provided by Financial Express. 
